Clinical Trial Update: IonMAN II Trial- Early Feasibility Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System [NA]

View source ↗

Summary

The IonMAN II early-feasibility trial of Medinol's IoNIR Ridaforolimus-eluting coronary stent system is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Stenosis

Drugs mentioned

• IoNIR Ridaforolimus-Eluting Coronary Stent System (ridaforolimus-eluting IoNIR coronary stent system)

Snippet

Sponsor: Medinol Ltd. | Conditions: Coronary Stenosis, Coronary Artery Disease | NA | Status: SUSPENDED